News: mRNA
Group of Bioinspired Materials and Devices Collaborates on mRNA Vaccine Development with BioCina and Cytiva, Supported by CRC-P and MRFF Grants
![BioCina logo](/bioinspired-materials-devices/sites/default/files/styles/ua_landscape/public/media/images/2022-08/biocina.jpg?h=c4dd2c7b&itok=7eP8oVCT)
The Group of Bioinspired Materials and Devices at the University of Adelaide is delighted to share an update on its collaboration with BioCina and Cytiva, focusing on the development of precision mRNA vaccines and RNA therapeutics. This partnership is fuelled by two significant grant awards: the $3.0m AUD Cooperative Research Centres Projects (CRC-P) grant “mRNA manufacturing and formulation service for late stage clinical trials” announced in April 2022, and the $5.0m AUD Medical Research Future Fund (MRFF) grant “mRNA Clinical Trial Enabling Infrastructure” announced in April 2023. The South Australian Government also contributes additional funding to support these innovative projects.